Rheumatology

APS

Questions discussed in this category

In a patient with known APS (triple positive) and interstitial lung disease (NSIP), how do you distinguish APS associated lung involvement from connective tissue disease related ILD?

Patient has a +ANA but no other clear clinical features of SLE or another defined connective tissue disease.

1 Answer available

Do you consider co-prescribing hormone therapy and anticoagulation in a patient with prior DVT and uncontrollable VSM uncontrolled by non-hormonal therapies?

4 Answers available

How do you approach recurrent migratory superficial thrombophlebitis in a patient with a negative malignancy workup and low-titer anticardiolipin antibodies?

1 Answer available

Papers discussed in this category

Blood, 2015 Dec 22

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

Menopause (New York, N.Y.), 2024 Feb 01

Does hormone therapy exacerbate other venous thromboembolism risk factors?

Research and practice in thrombosis and haemostasis, 2023 Apr 24

Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.

Seminars in respiratory and critical care medicine, 2019 May 28

Lung Disease in Antiphospholipid Syndrome.

Respiratory research, 2025 Nov 28

Antiphospholipid antibodies and subclinical interstitial lung disease in the MESA cohort.

The Journal of pathology, 2020 Mar 30

Critical role for iron accumulation in the pathogenesis of fibrotic lung disease.

Related Topics in Rheumatology